AAAAAA

   
Results: 1-17 |
Results: 17
DELAYED RECOVERY OF MYOCARDIAL PERFUSION IN ACUTE MYOCARDIAL-INFARCTION - A SCINTIGRAPHIC STUDY AFTER EARLY THROMBOLYTIC TREATMENT
Authors: BOUVIER F HOJER J SAMAD BA JENSENURSTAD K RUIZ H HULTING J JENSENURSTAD M
Citation: F. Bouvier et al., DELAYED RECOVERY OF MYOCARDIAL PERFUSION IN ACUTE MYOCARDIAL-INFARCTION - A SCINTIGRAPHIC STUDY AFTER EARLY THROMBOLYTIC TREATMENT, Coronary artery disease, 9(7), 1998, pp. 443-449
DELAYED RECOVERY OF MYOCARDIAL PERFUSION IN ACUTE MYOCARDIAL-INFARCTION - A SCINTIGRAPHIC STUDY AFTER EARLY THROMBOLYTIC TREATMENT
Authors: BOUVIER F HOJER J JENSENURSTAD K RUIZ H HULTING J JENSENURSTAD M
Citation: F. Bouvier et al., DELAYED RECOVERY OF MYOCARDIAL PERFUSION IN ACUTE MYOCARDIAL-INFARCTION - A SCINTIGRAPHIC STUDY AFTER EARLY THROMBOLYTIC TREATMENT, Journal of the American College of Cardiology, 31(2), 1998, pp. 519-519
MYOCARDIAL PERFUSION SCINTIGRAPHY (SPECT) DURING ADENOSINE STRESS CANBE PERFORMED SAFELY EARLY ON AFTER THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION
Authors: BOUVIER F HOJER J HULTING J RUIZ H SAMAD B JENSENURSTAD M
Citation: F. Bouvier et al., MYOCARDIAL PERFUSION SCINTIGRAPHY (SPECT) DURING ADENOSINE STRESS CANBE PERFORMED SAFELY EARLY ON AFTER THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION, Clinical physiology, 18(2), 1998, pp. 97-101
COMPARISON OF DIFFERENT ECHOCARDIOGRAPHIC METHODS WITH RADIONUCLIDE IMAGING FOR MEASURING LEFT-VENTRICULAR EJECTION FRACTION DURING ACUTE MYOCARDIAL-INFARCTION TREATED BY THROMBOLYTIC THERAPY
Authors: JENSENURSTAD K BOUVIER F HOJER J RUIZ H HULTING J SAMAD B THORSTRAND C JENSENURSTAD M
Citation: K. Jensenurstad et al., COMPARISON OF DIFFERENT ECHOCARDIOGRAPHIC METHODS WITH RADIONUCLIDE IMAGING FOR MEASURING LEFT-VENTRICULAR EJECTION FRACTION DURING ACUTE MYOCARDIAL-INFARCTION TREATED BY THROMBOLYTIC THERAPY, The American journal of cardiology, 81(5), 1998, pp. 538-544
NAPSAGATRAN, A NOVEL SYNTHETIC THROMBIN INHIBITOR, COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEAN MULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M
Citation: H. Bounameaux et al., NAPSAGATRAN, A NOVEL SYNTHETIC THROMBIN INHIBITOR, COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEAN MULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 1997, pp. 1191-1191
AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M RAMES A BASLE CH TENCATE JW SCHNEIDER PA GENEVA CH SCHMITT HE SLOSMAN DO PERRIER A SPANNAGL H GSCHWANDTNER ME BANYAI M KOPPENSTEINER R MINAR E STUMPFLEN A HAUMER M VERHAEGHE R VERMYLEN J WAUTRECHT JC TAGHIZADEH K BRUHN HD LINS M ZURBORN KH SCHWARZENBERG H SCHAUER J SCHEEL H RUHLMANN C VOIGT H WAGNER T SIEMENS HJ SCHWIEDER G HEENE D DEMPFLE CE HARENBERG J PFITZNER S BROCKHAUS W SCHUSTER O WEISSHAAR K SEBIGER R HOFMANN B ANDERS O KRAMMER B PLATH F LESTIN H BAUMANN N EHRERTREICH U MULLERESCH G RUPRECHT B WEDEEN G LARFARS G WALLVIK J BJUHR O DIDIER D DESMARAIS S WUTSCHERT R DEMOERLOOSE P CHRISTEN Y BERNARD C KUPKA S KIRISITS A JANSSEN M VERWEIJ G KRAAJ CJ SITTNER WD HANKA U MAIER A JOHANSSON AS JOHANSSON E OLESEN M BREIER E WITTKE B GOGGIN T STEPHENSON C TURKISH M WILLIAMS L DUTREIX C GAUTSCH A NONN D WARD R LOWE P LAD K GREEN D GRAVEL A
Citation: H. Bounameaux et al., AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 78(3), 1997, pp. 997-1002
A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY
Authors: GRIP L FRISON L WALLENTIN L DELLBORG M GRANDE P HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K SLEIGHT P WILHELMSEN L NASLUND U GUNDERSEN T FISCHERHANSEN J LEHTO S BARRET M NILSSON JE TEGERNILSSON AC THORSEN M ANDERSEN F LUNDSTROM M HILDEBRAND A DEFLONOLSSON C FORSBY M ISBERG P LARSSON C NORGAARD B RASMUSSEN S VIDEBAEK J KLARLUND K LANDORPH A NIELSEN T AGNER E HOJGAARD MV HELQVIST S RASMUSSEN SL EGSTRUP K MYGIND L HANSEN JF SAJADIEH A GILL S HAGHFELT T MARKENVARD J THOMASSEN A JENSEN N PETERSEN J JENSEN G FISCHER T SIPILA R KIILAVUORI K HAMALAINEN L NURMINEN J MELIN J KOSKELA E HURME H VAUHONEN I HONKANEN T UTRIANEN S HAMALAINEN T LILJA M UKKOLVA O KIVELA H SODERSTROM S POHJOLASINTONEN S HUSSI E LARSEN A FALANG JE SCHARTUMHANSEN H PAULSEN A OMLAND T HOLM T EDVARDSEN T THYBO NK HAEREM J KAPELRUD H WAAGE K ROSSEBO B HAFSOY K HAMMARSTROM E ASTROM L HALL E WETTERVIK C FORSBERG SA TYGESEN H FREDRIKSSON B EKDAHL S KIHLSTROM K MAGNUSSON JO STJERNA A MARU F NILSSON H AKRAWI S SAETRE H AHLMARK G AHLBERG G LINDE B HAGSTROM L GUSTAFSSON G GUSTAVSSON PE LARSSON AC ANDERSEN K RUTER G KIERKEGAARD A HARDHAMMAR P KARLSSON JE SVENSSON O LANDGREN F HOLMBERG B RYDEN S WEINER L DANIELEWICZ M MALMROS B NICOL P JANZON M OHLIN H HANSEN O TINGBERG E NYMAN I FJELSTAD B AHLSTROM P HEDBACK B PERK J SVENNBERG L ELLSTROM J BOMAN K REMMETS J KRISTENSSON BE LINDER R HULTING J HOIJER J MOLLER BH LYCKSELL M WAHLIN M SANDSTEDT L REDFORS A BORRETZEN J OSTBERG G JOHANSSON B MORNER S LINDAHL B OLDGREN J JONSSON J NEMECZE K THORSEN S JOHANSSON PA SINNERSTAD B LARSSON LE BAND S MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425
RISK STRATIFICATION IN UNSTABLE CORONARY-ARTERY DISEASE - ADDITIVE VALUE OF TROPONIN-T DETERMINATIONS AND PREDISCHARGE EXERCISE TESTS
Authors: LINDAHL B ANDREN B OHLSSON J VENGE P WALLENTIN L LUNDIN L TOSS H LINDAHL B LINDSTROM G SVENSSON E ALSJO G SLTRE H AHLBERG G HAGSTROM L SUNDQVIST C PIHL E GUSTAFSSON G LARSSON L GUSTAVSSON PE LOFMARK R LUNDQVIST IB HAMMARSTROM E BASTANI H ENG E LUNDIN P REHNQVIST N AMBRANT B OBLACK P HOLMSTRAND M FJELSTAD B ARONSON D OSTBERG S FRISELL JE HEDMAN A SANDSTROM M PERERS G IRVING P ANDERSSON I HULTING J HOJIER J AMANULLAH A SAMAD B STEINBRUCK I EKBLOM M SWAHN E KARLSSON E NIELSEN N SAFSTROM K LOGANDER E FALK SA FRIDEN J NILSSON O RONNHAGEN K ABOUZEID L HEDBACK B PERK J OSSIANSSONPETTERSSON L HOLMBERG B LANDGREN F RYDEN S BJURLING E KARLSSON JE MALMBERG C SVENSSON O SVENSSON E EKDAHL S NYMAN I PANTZAR Y ENGHOFF E LUNDSTROM T ANDREN B OHLSSON J WALLENTIN L OHLSSON J LINDSTROM G LOGANDER E SVENSSON E
Citation: B. Lindahl et al., RISK STRATIFICATION IN UNSTABLE CORONARY-ARTERY DISEASE - ADDITIVE VALUE OF TROPONIN-T DETERMINATIONS AND PREDISCHARGE EXERCISE TESTS, European heart journal, 18(5), 1997, pp. 762-770
THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S GRANQVIST S HOLMSTROM M CARLSSON A LINDMARKER P NICOL P EKLUND SG NORDLANDER S LARFARS G LEIJD B LINDER O LOOGNA E GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J SVENSSON E DAHLIN L BOBERG J MARJANOVICS B JONSSON KA MALM C HJORTH M LINDGREN A FAGRELL B KALLNER M WADMAN B SNYDER M
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(6), 1997, pp. 393-398
THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S WIMAN B CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORTH M FAGRELL B KALLNER M GRANQVIST S EGBERG N SCHULMAN S WADMAN B SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
LOW-MOLECULAR-WEIGHT HEPARIN DURING INSTABILITY IN CORONARY-ARTERY DISEASE
Authors: WALLENTIN L OHLSSON J SWAHN E KARLSSON E LUNDIN L LANDGREN F SAETRE H ADREN B ENGHOFF E LUNDSTROM T HJALMARSSON A NORDLANDER R ANDREN B BLOMSTRAND P VENGE P SIEGBAHN A ALMROTH G JOHANSSON C NORMARK A WIKLUND K LOGANDER E LINDSTROM G SVENSSON E UNDELAND S NEIGER K PERERS G IRVING P ANDERSSON I HAMMARSTROM E BASTANI H ENG E LUNDIN P REHNQVIST N AMBRANT B OBLACK P HOLMSTRAND M EKDAHL S NYMAN I PANTZAR Y AHLBERG G HAGSTROM L SUNDQVIST C PIHL E GUSTAFSSON G LARSSON L GUSTAVSSON PE LOFMARK R LUNDQVIST IB LUNDQVIST L ANGMAN K KARLSSON JE SVENSSON O MALMBERG C HOLMBERG B RYDEN S BJURLING E ABJORN C WAHLFORS AL MALMROS B NICOL P ROWA M NIELSEN N SAFSTROM K FRISELL JE HEDMAN A SANDSTOM M AHLSTROM P ROSENQVIST U RYDEN BO GUSTAVSSON SB ALMEN I FJELSTAD B ARONSON D OSTBERG S FALK SA FRIDEN J NILSSON O RONNHAGEN K ABOUZEID L HEDBACK B PERK J OSSIANSSONPETTERSSON L ELLSTROM J BRODERSSON H VONHOLST M KJELLINWIBERG A HULTING J HOJIER J AMANULLAH A SAMAD B STEINBRUCK I EKBLOM M TOSS H LINDAHL B ALSJO G SINNERSTAD B LARSSON LE NILSSON G AGERT G WIBERG S PIHLSTROM B JOHANSSON PA LIND O THORSEN S EKBERG K
Citation: L. Wallentin et al., LOW-MOLECULAR-WEIGHT HEPARIN DURING INSTABILITY IN CORONARY-ARTERY DISEASE, Lancet, 347(9001), 1996, pp. 561-568
ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION-II SCORING SYSTEM IN ACUTE MYOCARDIAL-INFARCTION - A PROSPECTIVE VALIDATION-STUDY
Authors: LUDWIGS U HULTING J
Citation: U. Ludwigs et J. Hulting, ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION-II SCORING SYSTEM IN ACUTE MYOCARDIAL-INFARCTION - A PROSPECTIVE VALIDATION-STUDY, Critical care medicine, 23(5), 1995, pp. 854-859
A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S RHEDIN AS LINDMARKER P CARLSSON A LARFARS G NICOL P LOOGNA E SVENSSON E LJUNGBERG B WALTER H VIERING S NORDLANDER S LEIJD B JONSSON KA HJORTH M LINDER O BOBERG J GUSTAFSSON C GRONDAHL A TORNEBOHM E JOHANSSON M LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R WILHELMSSON S OHLSSON A MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J EKLUND SG DAHLIN L MARJANOVICS B MALM C LINDGREN A FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N WADMAN B SNYDER M
Citation: S. Schulman et al., A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 332(25), 1995, pp. 1661-1665
QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN
Authors: SCHULMAN S CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORT M FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N
Citation: S. Schulman et al., QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN, Journal of internal medicine, 236(2), 1994, pp. 143-152
CREATINE KINASE-MB MASS CONCENTRATION VERSUS CREATINE KINASE-B ACTIVITY FOR THE DETECTION OF ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITH SLIGHTLY ELEVATED TOTAL CREATINE-KINASE ACTIVITY IN SERUM
Authors: HULTING J WALDENLIND L ONICA D WALLINDER H
Citation: J. Hulting et al., CREATINE KINASE-MB MASS CONCENTRATION VERSUS CREATINE KINASE-B ACTIVITY FOR THE DETECTION OF ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITH SLIGHTLY ELEVATED TOTAL CREATINE-KINASE ACTIVITY IN SERUM, Journal of internal medicine, 235(3), 1994, pp. 211-216
PROGNOSTIC VALUE OF PLASMA NEUROPEPTIDE-Y IN CORONARY-CARE UNIT PATIENTS WITH AND WITHOUT ACUTE MYOCARDIAL-INFARCTION
Authors: ULLMAN B HULTING J LUNDBERG JM
Citation: B. Ullman et al., PROGNOSTIC VALUE OF PLASMA NEUROPEPTIDE-Y IN CORONARY-CARE UNIT PATIENTS WITH AND WITHOUT ACUTE MYOCARDIAL-INFARCTION, European heart journal, 15(4), 1994, pp. 454-461
NEUROPEPTIDE-Y, NORADRENALINE AND INVASIVE HEMODYNAMIC DATA IN MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE
Authors: ULLMAN B JENSENURSTAD M HULTING J LUNDBERG JM
Citation: B. Ullman et al., NEUROPEPTIDE-Y, NORADRENALINE AND INVASIVE HEMODYNAMIC DATA IN MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE, Clinical physiology, 13(4), 1993, pp. 409-418
Risultati: 1-17 |